Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Aug 21;74(5):2452–2466. doi: 10.1002/hep.31995

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2021 The Authors. Hepatology published by Wiley Periodicals LLC on behalf of American Association for the Study of Liver Diseases.

This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.

PMC Copyright notice

FIG. 4 — Serum TSP‐2 levels discriminated NASH from NAFL among patients with NAFLD patients. (A) Relative serum TSP‐2 levels in 121 patients with NAFL and 92 patients with NASH (*P < 0.01). (B) Receiver operating characteristic curve of the performance of serum TSP‐2 levels in the diagnosis of NASH among 213 patients with biopsy‐proven NAFLD. The AUROC is shown. (C) Relative serum TSP‐2 levels based on the NAS (*P < 0.01). (D) Relative serum TSP‐2 levels based on the steatosis (left), inflammation (middle), and ballooning (right) scores of the NAS (*P < 0.01).